Skip to content

Shanghai HeartCare Medical Technology Co Ltd Sustainability Reports

The company engages in the research, development, manufacture, and sale of neuro-interventional and cardiac medical devices in China. Its products primarily target acute ischemic stroke, neurovascular stenosis, and hemorrhagic stroke treatment.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

FIGI: BBG00W4M1NJ4

9 reports from 2021 to 2025